United Orthopedic Corporation (TPEX:4129)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
99.40
-1.10 (-1.09%)
Apr 29, 2026, 12:29 PM CST
12.32%
Market Cap 9.69B
Revenue (ttm) 5.66B
Net Income (ttm) 562.02M
Shares Out 96.44M
EPS (ttm) 5.67
PE Ratio 17.72
Forward PE 14.41
Dividend 4.50 (4.50%)
Ex-Dividend Date Jul 23, 2025
Volume 170,176
Average Volume 278,479
Open 100.00
Previous Close 100.50
Day's Range 99.10 - 100.00
52-Week Range 85.00 - 131.50
Beta 0.52
RSI 41.47
Earnings Date May 8, 2026

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee joints, including artificial knee replacement joints, revision knee replacement systems, restricted artificial knee joints, and customized artificia... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1993
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4129
Full Company Profile

Financial Performance

In 2025, United Orthopedic's revenue was 5.66 billion, an increase of 21.54% compared to the previous year's 4.65 billion. Earnings were 562.02 million, an increase of 23.14%.

Financial Statements

News

There is no news available yet.